[The effect of hormonal therapy on the breast in the climacteric syndrome in women].
The author observed three groups of women during their receiving hormonal therapy for the climacteric syndrome. They underwent clinical investigation, mammography and thermography. The first group (n = 31) received 10 mg estradiolmonobenzoate every 6 weeks, the second group (n = 33) 2.5 mg estradiolmonobenzoate and 50 mg testosteroneisobutyrate every 6 weeks. The control group (n = 50) received no hormonal therapy. According to the results obtained, no statistically significant changes were observed following the hormonal therapy.